rivaroxaban우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 41055699
Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022-2024).
Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022-2024).
- 저자
- Michael Kunz, Andrea Espinosa Daudí, Marita Kieble, Ulrich Laufs, Felix Götzinger, Jasper Boeddinghaus
- 저널
- Clinical research in cardiology : official journal of the German Cardiac Society
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.1007/s00392-025-02761-x
문헌 요약
This study aimed to investigate the prescription rates of low-dose antithrombotic and anti-inflammatory therapies in Germany from 2022 to 2024. We analyzed national outpatient claims data from the German Institute for Drug Use Evaluation. Claims data for patients receiving the following medications were included: aspirin 100 mg, clopidogrel 75 mg, prasugr…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.